Nav: Home

Inflammatory marker linked to dementia

December 09, 2019

An inflammatory marker called sCD14 is related to brain atrophy, cognitive decline and dementia, according to a study of more than 4,700 participants from two large community-based heart studies. The study was published Monday, Dec. 9, in the journal Neurology.

"We have strong reason to believe that sCD14 can be a useful biomarker to assess a person's risk of cognitive decline and dementia," said study senior author Sudha Seshadri, M.D., professor of neurology at UT Health San Antonio and director of the university's Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases.

"The most exciting part is that we could assess this risk in advance, when there is ample time to intervene and change the course of a person's life," Dr. Seshadri said.

"Higher levels of sCD14 were associated with markers of brain aging and injury, such as total brain atrophy and a decline in executive functioning--the decision-making needed for many activities of daily life," said study lead author Matthew Pase, Ph.D., of the Florey Institute for Neuroscience and Mental Health in Melbourne, Australia.

The researchers studied risk of dementia in 1,588 participants from the Framingham Heart Study and 3,129 participants from the Cardiovascular Health Study. Dr. Pase and Dr. Seshadri are Framingham investigators.

Plasma sCD14 was measured in participants' blood upon study enrollment. In the Framingham group, brain MRI and cognitive testing were performed within one year after the blood draw for sCD14. A second round of tests was performed after seven years. Surveillance for dementia was conducted over an average of nine years.

In the Cardiovascular Health Study, the first brain MRI was obtained three to four years after enrollment and a second round five years later.

"Cost-effective, blood based biomarkers are greatly needed to detect and track the progression of preclinical brain injury predisposing to dementia," the researchers state in the paper. "Such biomarkers could also act as endpoints in clinical trials of disease-modifying interventions and expand our understanding of disease biology."

There are not yet any drug trials to see if lowering sCD14 levels would help cognition in humans. However, treatment with several targeted anti-inflammatory medications--such as statins--can lower sCD14. "There is a growing recognition of the role of inflammation in neurodegeneration and vascular injury-related cognitive decline and dementia," Dr. Seshadri said.
-end-
Reference: "Association of CD14 with incident dementia and markers of brain aging and injury," Neurology, Matthew P. Pase, et al.

Funding: National Heart Foundation of Australia Future Leader Fellowship; National Heart, Lung, and Blood Institute, U.S.A.; National Institute on Aging, U.S.A.; National Institute of Neurological Disorders and Stroke, U.S.A.

Acknowledgment: The authors thank the Framingham Heart Study and Cardiovascular Health Study participants for their time.

Stay connected with UT Health San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.

The University of Texas Health Science Center at San Antonio, now called UT Health San Antonio®, is one of the country's leading health sciences universities. With missions of teaching, research, healing and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced 36,500 alumni who are leading change, advancing their fields and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways "We make lives better®," visit http://www.uthscsa.edu.

University of Texas Health Science Center at San Antonio

Related Dementia Articles:

Dementia education
School-based dementia education could deliver much needed empathy and understanding for older generations as new research from the University of South Australia shows it can significantly improve dementia knowledge and awareness among younger generations.
Building dementia friendly churches
A project to help church communities become more 'dementia friendly' has had a significant impact across the country.
A "feeling" for dementia?
A research team led by the DZNE concludes that personal perception can be an important indicator for the early detection of Alzheimer's disease.
New biomarker for dementia diagnosis
Medical researchers in the UK and Australia have identified a new marker which could support the search for novel preventative and therapeutic treatments for dementia.
Digital solutions for dementia care
Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.
Despite a marked reduction in the prevalence of dementia, the number of people with dementia is set to double by 2050 according to new Alzheimer Europe report
Today, at a European Parliament lunch debate, Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.
Inflammatory marker linked to dementia
Higher levels of an inflammatory marker, sCD14, were associated with brain atrophy, cognitive decline and dementia in two large heart studies.
How likely do you think you are to develop dementia?
A poll suggests almost half of adults ages 50 to 64 believe they're likely to develop dementia.
Latest issue of Alzheimer's & Dementia
Predicting heart disease might also be a warning sign for Alzheimer's; A new way to think about the environment and Alzheimer's research; Most dementia patients don't receive care from physicians who specialize in brain health.
What multilingual nuns can tell us about dementia
A strong ability in languages may help reduce the risk of developing dementia, says a new University of Waterloo study.
More Dementia News and Dementia Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Debbie Millman: Designing Our Lives
From prehistoric cave art to today's social media feeds, to design is to be human. This hour, designer Debbie Millman guides us through a world made and remade–and helps us design our own paths.
Now Playing: Science for the People

#574 State of the Heart
This week we focus on heart disease, heart failure, what blood pressure is and why it's bad when it's high. Host Rachelle Saunders talks with physician, clinical researcher, and writer Haider Warraich about his book "State of the Heart: Exploring the History, Science, and Future of Cardiac Disease" and the ails of our hearts.
Now Playing: Radiolab

Insomnia Line
Coronasomnia is a not-so-surprising side-effect of the global pandemic. More and more of us are having trouble falling asleep. We wanted to find a way to get inside that nighttime world, to see why people are awake and what they are thinking about. So what'd Radiolab decide to do?  Open up the phone lines and talk to you. We created an insomnia hotline and on this week's experimental episode, we stayed up all night, taking hundreds of calls, spilling secrets, and at long last, watching the sunrise peek through.   This episode was produced by Lulu Miller with Rachael Cusick, Tracie Hunte, Tobin Low, Sarah Qari, Molly Webster, Pat Walters, Shima Oliaee, and Jonny Moens. Want more Radiolab in your life? Sign up for our newsletter! We share our latest favorites: articles, tv shows, funny Youtube videos, chocolate chip cookie recipes, and more. Support Radiolab by becoming a member today at Radiolab.org/donate.